Korean J Ophthalmol.  2011 Dec;25(6):401-408. 10.3341/kjo.2011.25.6.401.

Comparison of the Outcome of Repeat Trabeculectomy with Adjunctive Mitomycin C and Initial Trabeculectomy

• Cankaya AB
• Elgin U

• KMID: 1031187
• DOI: http://doi.org/10.3341/kjo.2011.25.6.401

Abstract

PURPOSE
To compare the efficacy and safety of repeat and initial trabeculectomy with mitomycine C (MMC).
METHODS
Eighty seven patients, who had underwent repeat (repeat group) or initial (initial group) trabeculectomy with MMC, were enrolled in this prospective trial. Postoperative outcome measures included the amount of decrease in intraocular pressure (IOP), the number of anti-glaucoma medications, and the complications. The success of trabeculectomy was defined on the basis of three definitions which were: IOP < or =18 mmHg (definition 1), IOP < or =21 mmHg (definition 2), and the amount of decrease in IOP from baseline > or =30% (definition 3). Success was further defined as "complete" when these criteria were obtained without any anti-glaucoma medications and "qualified" with or without medical therapy and no further surgical procedures.
RESULTS
Fifty nine eyes underwent initial and 28 eyes underwent repeat trabeculectomy. The mean follow-up period was 19.1 +/- 5.9 months. Complete success rates were significantly greater in the initial trabeculectomy group (p = 0.02 for definition 1, p = 0.038 for definition 2, p = 0.003 for definition 3). A higher proportion of eyes in the initial group achieved qualified success relative to the group A eyes, but the differences were not statistically significant (p = 0.33 for definition 1, p = 0.99 for definition 2, p = 0.24 for definition 3). The mean number of antiglaucomatous medications at the last examination was 1.2 +/- 1.2 in repeat group and 0.7 +/- 1.1 in initial group (p = 0.01). The number of complications during the follow up period did not differ significantly between the two groups (p = 0.65).
CONCLUSIONS
Repeat trabeculectomy with MMC has high success and low complication rates in patients with previously failed trabeculectomy in spite of the need of higher number of anti-glaucoma medications.

Keyword

Initial trabeculectomy; Mitomycin C; Repeat trabeculectomy

MeSH Terms

Aged
Alkylating Agents/*administration & dosage
Combined Modality Therapy
Female
Follow-Up Studies
Glaucoma/*drug therapy/*surgery
Humans
Intraocular Pressure/physiology
Male
Middle Aged
Mitomycin/*administration & dosage
Prospective Studies
Reoperation
*Trabeculectomy
Treatment Outcome

Figure

• 

  Fig. 1 Kaplan-Meier survival analysis of complete success rates of intraocular pressure control. (A) Definition 1, (B) definition 2, (C) definition 3. trab = trabeculectomy.

• 

  Fig. 2 Kaplan-Meier survival analysis of qualified success rates of intraocular pressure control. (A) Definition 1, (B) definition 2, (C) definition 3. trab = trabeculectomy.

Reference

1. Chen TC, Wilensky JT, Viana MA. Long-term follow-up of initially successful trabeculectomy. Ophthalmology. 1997. 104:1120–1125.

2. Nouri-Mahdavi K, Brigatti L, Weitzman M, Caprioli J. Outcomes of trabeculectomy for primary open-angle glaucoma. Ophthalmology. 1995. 102:1760–1769.

3. Vesti E, Raitta C. A review of the outcome of trabeculectomy in open-angle glaucoma. Ophthalmic Surg Lasers. 1997. 28:128–132.

4. Jacobi PC, Dietlein TS, Krieglstein GK. Primary trabeculectomy in young adults: long-term clinical results and factors influencing the outcome. Ophthalmic Surg Lasers. 1999. 30:637–646.

5. Shigeeda T, Tomidokoro A, Chen YN, et al. Long-term follow-up of initial trabeculectomy with mitomycin C for primary open-angle glaucoma in Japanese patients. J Glaucoma. 2006. 15:195–199.

6. Suzuki R, Dickens CJ, Iwach AG, et al. Long-term follow-up of initially successful trabeculectomy with 5-fluorouracil injections. Ophthalmology. 2002. 109:1921–1924.

7. The Fluorouracil Filtering Surgery Study Group. Five-year follow-up of the Fluorouracil Filtering Surgery Study. Am J Ophthalmol. 1996. 121:349–366.

8. The Fluorouracil Filtering Surgery Study Group. Fluorouracil Filtering Surgery Study one-year follow-up. Am J Ophthalmol. 1989. 108:625–635.

9. Broadway DC, Grierson I, Hitchings RA. Local effects of previous conjunctival incisional surgery and the subsequent outcome of filtration surgery. Am J Ophthalmol. 1998. 125:805–818.

10. Zalish M, Oron Y, Geyer O. Outcome of consecutive trabeculectomy. Clin Experiment Ophthalmol. 2004. 32:19–22.

11. Katz GJ, Higginbotham EJ, Lichter PR, et al. Mitomycin C versus 5-fluorouracil in high-risk glaucoma filtering surgery. Extended follow-up. Ophthalmology. 1995. 102:1263–1269.

12. Broadway DC, Grierson I, O'Brien C, Hitchings RA. Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery. Arch Ophthalmol. 1994. 112:1446–1454.

13. Broadway DC, Chang LP. Trabeculectomy, risk factors for failure and the preoperative state of the conjunctiva. J Glaucoma. 2001. 10:237–249.

14. Shetty RK, Wartluft L, Moster MR. Slit-lamp needle revision of failed filtering blebs using high-dose mitomycin C. J Glaucoma. 2005. 14:52–56.

15. Anand N, Arora S. Surgical revision of failed filtration surgery with mitomycin C augmentation. J Glaucoma. 2007. 16:456–461.

16. You YA, Gu YS, Fang CT, Ma XQ. Long-term effects of simultaneous subconjunctival and subscleral mitomycin C application in repeat trabeculectomy. J Glaucoma. 2002. 11:110–118.

17. Cohen JS, Novack GD, Li ZL. The role of mitomycin treatment duration and previous intraocular surgery on the success of trabeculectomy surgery. J Glaucoma. 1997. 6:3–9.

18. Singh K, Egbert PR, Byrd S, et al. Trabeculectomy with intraoperative 5-fluorouracil vs mitomycin C. Am J Ophthalmol. 1997. 123:48–53.

19. Mermoud A, Salmon JF, Murray AD. Trabeculectomy with mitomycin C for refractory glaucoma in blacks. Am J Ophthalmol. 1993. 116:72–78.

20. Siriwardena D, Edmunds B, Wormald RP, Khaw PT. National survey of antimetabolite use in glaucoma surgery in the United Kingdom. Br J Ophthalmol. 2004. 88:873–876.

21. Radius RL, Herschler J, Claflin A, Fiorentino G. Aqueous humor changes after experimental filtering surgery. Am J Ophthalmol. 1980. 89:250–254.

22. Joseph JP, Grierson I, Hitchings RA. Chemotactic activity of aqueous humor. A cause of failure of trabeculectomies? Arch Ophthalmol. 1989. 107:69–74.

23. Costa VP, Spaeth GL, Eiferman RA, Orengo-Nania S. Wound healing modulation in glaucoma filtration surgery. Ophthalmic Surg. 1993. 24:152–170.

24. Jampel HD. Effect of brief exposure to mitomycin C on viability and proliferation of cultured human Tenon's capsule fibroblasts. Ophthalmology. 1992. 99:1471–1476.

25. Khaw PT, Doyle JW, Sherwood MB, et al. Effects of intraoperative 5-fluorouracil or mitomycin C on glaucoma filtration surgery in the rabbit. Ophthalmology. 1993. 100:367–372.

26. Palmer SS. Mitomycin as adjunct chemotherapy with trabeculectomy. Ophthalmology. 1991. 98:317–321.

27. Chen CW, Huang HT, Bair JS, Lee CC. Trabeculectomy with simultaneous topical application of mitomycin-C in refractory glaucoma. J Ocul Pharmacol. 1990. 6:175–182.

28. King AJ, Rotchford AP, Alwitry A, Moodie J. Frequency of bleb manipulations after trabeculectomy surgery. Br J Ophthalmol. 2007. 91:873–877.

29. Broadway DC, Bloom PA, Bunce C, et al. Needle revision of failing and failed trabeculectomy blebs with adjunctive 5-fluorouracil: survival analysis. Ophthalmology. 2004. 111:665–673.

30. Gutierrez-Ortiz C, Cabarga C, Teus MA. Prospective evaluation of preoperative factors associated with successful mitomycin C needling of failed filtration blebs. J Glaucoma. 2006. 15:98–102.

31. Law SK, Shih K, Tran DH, et al. Long-term outcomes of repeat vs initial trabeculectomy in open-angle glaucoma. Am J Ophthalmol. 2009. 148:685.e1–695.e1.